Seres Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Seres Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q2 2025.
  • Seres Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2025 was 8.75M shares, a 94.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 8.75M -143M -94.2% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 8.73M -143M -94.2% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 8.65M -126M -93.6% Dec 31, 2024 10-Q 2025-08-06
Q3 2024 170M +41.6M +32.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 152M +23.6M +18.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 151M +24.8M +19.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 135M +9.82M +7.84% Dec 31, 2023 10-K 2025-03-13
Q3 2023 129M +4.22M +3.39% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 128M +35.7M +38.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 127M +34.4M +37.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 125M +33.3M +36.3% Dec 31, 2022 8-K 2024-08-15
Q3 2022 124M +32.6M +35.5% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 92.3M +593K +0.65% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 92.2M +622K +0.68% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 91.9M +430K +0.47% Dec 31, 2021 10-K 2023-03-07
Q3 2021 91.8M +627K +0.69% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 91.7M +16.6M +22.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 91.6M +19.9M +27.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 91.5M +21.3M +30.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 91.2M +21.2M +30.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 75.1M +5.22M +7.46% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 71.7M +30.6M +74.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 70.1M +29.2M +71.3% Dec 31, 2019 10-K 2021-03-02
Q3 2019 70M +29.1M +71.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 69.9M +29.2M +71.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.1M +442K +1.09% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 40.9M +366K +0.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 40.8M +332K +0.82% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 40.8M +343K +0.85% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 40.7M +266K +0.66% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 40.6M +215K +0.53% Dec 31, 2017 10-K 2019-03-06
Q3 2017 40.5M +157K +0.39% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 40.4M +553K +1.39% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 40.4M +1.17M +2.98% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 40.4M +1.27M +3.26% Dec 31, 2016 10-K 2018-03-08
Q3 2016 40.4M +1.3M +3.33% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 39.9M +9.44M +31% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 39.2M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 39.1M +32.2M +467% Dec 31, 2015 10-K 2017-03-16
Q3 2015 39.1M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 30.4M Jun 30, 2015 10-Q 2015-08-10
Q4 2014 6.89M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.